The new risk variant CACNA1C and brain circuits in schizophrenia Andrea SchmittPeter Falkai Editorial 31 January 2014 Pages: 91 - 92
CACNA1C genotype explains interindividual differences in amygdala volume among patients with schizophrenia Claudia WolfHolger MohrOliver Gruber Original Paper 24 July 2013 Pages: 93 - 102
A genome-wide supported variant in CACNA1C influences hippocampal activation during episodic memory encoding and retrieval Axel KrugStephanie H. WittTilo Kircher Original Paper 17 July 2013 Pages: 103 - 110
Thalamocortical connectivity during resting state in schizophrenia Carsten M. KlingnerKerstin LangbeinIgor Nenadic Original Paper 27 July 2013 Pages: 111 - 119
Differential effects of antipsychotics on the development of rat oligodendrocyte precursor cells exposed to cuprizone Haiyun XuHong-Ju YangXin-Min Li Original Paper 01 June 2013 Pages: 121 - 129
Flupentixol use and adverse reactions in comparison with other common first- and second-generation antipsychotics: data from the AMSP study R. GrohmannR. R. EngelS. Stübner Original Paper 09 July 2013 Pages: 131 - 141
Neural correlates of semantic associations in patients with schizophrenia Katharina SassStefan HeimTilo Kircher Original Paper 24 July 2013 Pages: 143 - 154
Shades of vulnerability: latent structures of clinical caseness in prodromal and early phases of schizophrenia Andrea RaballoAnna MeneghelliHeinz Häfner Original Paper 09 July 2013 Pages: 155 - 169
A composite scale applied to evaluate anxiety in schizophrenic patients (SAES) Pierre-Michel LlorcaChristophe LanconFranck J. Bayle Original Paper 15 June 2013 Pages: 171 - 178
Comparative analysis of anti-toxoplasmic activity of antipsychotic drugs and valproate Guillaume FondAlexandra MacgregorJean-Francois Dubremetz Short Communication 15 June 2013 Pages: 179 - 183
